LYMPHOQUANT

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LYMPHOQUANT was filed as Word mark on 02/27/2018 at the World Intellectual Property Organization.

Trademark Details Last update: October 20, 2022

Trademark form Word mark
File reference 1404600
Countries Switzerland China em Japan South Korea
Base trademark US No. 87588377, August 29, 2017
Application date February 27, 2018
Expiration date February 27, 2028

Trademark owner

10222 Barnes Canyon Road,
Building 1
US

Trademark representatives

Level 43, Bourke Place, 600 Bourke Street AU

goods and services

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Trademark history

Date Document number Area Entry
June 1, 2019 2019/23 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 15, 2019 2019/16 Gaz CH Rejection
February 28, 2019 2019/9 Gaz JP Rejection
December 10, 2018 2019/1 Gaz CN Rejection
November 21, 2018 2018/47 Gaz KR Rejection
November 6, 2018 2018/45 Gaz EM Rejection
February 27, 2018 2018/20 Gaz US Registration

ID: 141404600